CreatorWeek 2025 Launches in Macao, Offering a Unique, Vibrant Platform for Global Content Creators to Connect, Collaborate, and Innovate
MACAO, Oct. 27, 2025 /PRNewswire/ -- CreatorWeek Macao 2025, co-organized by Macao…
Real-World Data Presented at TCT 2025 Demonstrates the EggNest Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team
SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular…
Kolmar Korea Selected for Government-Led ‘AI Factory’ Initiative — Driving Innovation in K-Beauty Manufacturing
The only cosmetics company chosen by the Ministry of Trade, Industry and…
Hyundai Motor Group and Toray Group Strengthen Ties to Develop Advanced Materials for Future Mobility
Hyundai Motor Group and Toray Group to develop advanced materials for future…
Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimers Disease
In Canada, lecanemab is indicated for the treatment of adult patients with…
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
October 25, 2025 11:01 ET | Source: Cullinan Therapeutics, Inc. CLN-978 led…
Hope in Syria: Education Cannot Wait investments support teacher training and continued learning for displaced children in Syria
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- In the heart of a…
Singtel’s RE:AI Receives Frost & Sullivan’s 2025 Southeast Asia Competitive Strategy Leadership Recognition for Excellence in GPU-as-a-Service Innovation
By integrating compute, connectivity, applications and orchestration, RE:AI sets new standards for…
Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, in Patients with Advanced Solid Tumors
– QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and…
Cipla Health welcomes FSSAI’s new labelling rules for ‘ORS’, reinforces Prolyte ORS as the #AsliORS
MUMBAI, India, Oct. 24, 2025 /PRNewswire/ -- ProlyteORS, the flagship brand of…
